Definium Therapeutics Announces Positive Topline Results from Phase 3 Panorama Study of DT120 ODT in Generalized Anxiety Disorder

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/22/2026

1. USO
2. META
3. NVDA
4. SPY
5. DCOY
6. MSFT
7. VKTX
8. PRGS
9. LGND
10. INNV

Go back to Definium Therapeutics Announces Positive Topline Results from Phase 3 Panorama Study of DT120 ODT in Generalized Anxiety Disorder
(NASDAQ: DFTX) Delayed: 40.32 +1.04 (2.65%)
Previous Close $39.28    52 Week High $ 
Open $39.42    52 Week Low $ 
Day High $40.39    P/E N/A 
Day Low $38.70    EPS $ 
Volume 1,753,482